Projects



Results 1-12 of 12 (Search time: 0.004 seconds).

Start DateTitleP-InvestigatorFunding Organization/經費來源
2023Spint1-As1 Regulates Immune Microenvironment and Immune Evasion in Lung Cancer.SHANG-GIN WUNational Science and Technology Council
2022Mir-204 Regulates Immune Evasion and Tumor Microenvironment in Lung Cancer.(III)SHANG-GIN WUNational Science and Technology Council
2021Mir-204 Regulates Immune Evasion and Tumor Microenvironment in Lung Cancer. (II)SHANG-GIN WUNational Science and Technology Council
2020Mir-204 Regulates Immune Evasion and Tumor Microenvironment in Lung Cancer (1/3)SHANG-GIN WUNational Science and Technology Council
2019Explore the Promoter Regulation and Downstream Targets of Mir-204 to Control Tumor Progression and Lung Cancer Treatments.SHANG-GIN WUNational Science and Technology Council
2018Explore the Promoter Regulation and Downstream Targets of Mir-204 to Control Tumor Progression and Lung Cancer Treatments.SHANG-GIN WUNational Science and Technology Council
2017Explore the Promoter Regulation and Downstream Targets of Mir-204 to Control Tumor Progression and Lung Cancer Treatments.SHANG-GIN WUNational Science and Technology Council
2015Wnt5a Enhances Resistance of Nsclc Cells to EGFR-TKI InhibitorsSHANG-GIN WUNational Science and Technology Council
2014Anti-Apoptosis and DNA Methylation of IGFBP-7 Induced EGRF Tyrosine Kinase Inhibitor and ResistanceSHANG-GIN WUNational Science and Technology Council
2013Anti-apoptosis and DNA methylation of IGFBP-7 induced EGFR tyrosine kinase inhibitor and resistanceSHANG-GIN WUNational Science and Technology Council
2012Anti-Apoptosis and Dna Methylation of Igfbp-7 Induced Egfr Tyrosine Kinase Inhibitor and ResistanceSHANG-GIN WUNational Science and Technology Council
2011The Role of IGFBP-7 in the Mechanism of Resistance to EGFR Tyrosine Kinase InhibitorSHANG-GIN WUNational Science and Technology Council